Cancer is a leading cause of death worldwide and it has been estimated that 5-10% of all cancers are hereditary i.e. passed down from one generation to the next. Genetic Testing for the presence of germline genetic variants provides many benefits to patients and their family members and forms an important part of cancer care.
Genetic testing for hereditary cancer can help you, the healthcare practitioner, to:
Genseq offer a range of Hereditary Cancer gene panels (see table below). These are in silico panels based on whole exome sequencing (WES) data. All panels include single nucleotide variants (SNV), small insertions/deletions (indels), and copy number variation (CNV) analysis.
HCE1004
Comprehensive Hereditary Cancer Panel
134
ABRAXAS1, ACD, AIP, AKT1, ALK, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRAF, BRCA1, BRCA2, BRIP1, CBL, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CDKN2B, CHEK2, CTC1, CTNNA1, DDB2, DICER1, DKC1, EGFR, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, FAM111B, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCL, FANCM, FH, FLCN, GREM1, HOXB13, HRAS, KIF1B, KIT, KITLG, KRAS, LZTR1, MAP2K1, MAP2K2, MAX, MBD4, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NRAS, NTHL1, PALB2, PARN, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POLH, POT1, PPP1CB, PRKAR1A, PRSS1, PTCH1, PTEN, PTPN11, RAD50, RAD51C, RAD51D, RAF1, RB1, RECQL, RET, RIT1, RNF43, RTEL1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SHOC2, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SOS1, SOS2, SPINK1, SPRED1, STK11, SUFU, TERC, TERF2IP, TERT, TINF2, TMEM127, TP53, TSC1, TSC2, VHL, WRAP53, WRN, WT1, XPA, XPC, XRCC2
HCE1001
Hereditary Breast Cancer Panel
8
BRCA1, BRCA2, CDH1, PALB2, PTEN, RECQL, STK11, TP53
HCE1002
Hereditary Breast and Gynaecological Cancer Panel
28
ATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCM, MLH1, MRE11, MSH2, MSH6, NBN, NF1, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2
HCE1001b
Hereditary Cancer - BRCA1/BRCA2
2
BRCA1, BRCA2
HCE1003b
Hereditary Cancer - Lynch Syndrome Panel
5
EPCAM, MLH1, MSH2, MSH6, PMS2
HCE1005
Hereditary Cancer High Risk Panel
28
APC, ATM, BAP1, BMPR1A, BRCA1, BRCA2, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, MEN1, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, RET, SMAD4, STK11, TP53, VHL
HCE1003
Hereditary Colorectal Cancer and Polyposis Panel
21
APC, AXIN2, BLM, BMPR1A, CDH1, EPCAM, GREM1, MBD4, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53
HCE1006
Hereditary Endocrine Cancer Panel
22
AIP, APC, CDC73, CDKN1B, DICER1, FH, MAX, MEN1, MET, NF1, PRKAR1A, PTEN, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, TP53, VHL, WRN
HCE1007
Hereditary Gastrointestinal Cancer Panel
19
APC, ATM, BMPR1A, BRCA1, BRCA2, CDH1, CTNNA1, EPCAM, KIT, MLH1, MSH2, MSH6, MUTYH, PALB2, PDGFRA, PMS2, SMAD4, STK11, TP53
HCE1008
5
BRCA2, CDKN2A, EGFR, FAM111B, TP53
HCE1009
Hereditary Melanoma and Skin Cancer Panel
22
ACD, BAP1, BRCA1, BRCA2, CDK4, CDKN2A, DDB2, ERCC2, ERCC3, ERCC4, ERCC5, MITF, POT1, PTCH1, PTEN, SUFU, TERF2IP, TERT, TP53, WRN, XPA, XPC
HCE1010
Hereditary Pancreatic Cancer Panel
16
APC, ATM, BRCA1, BRCA2, CDK4, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, TP53
HCE1013
Hereditary Paraganglioma Pheochromocytoma Panel
14
FH, KIF1B, MAX, MEN1, NF1, PRKAR1A, RET,SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL
HCE1011
Hereditary Prostate Cancer Panel
12
ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, TP53
HCE1012
20
BAP1, CDKN2B, EPCAM, FH, FLCN, MET, MITF, MLH1, MSH2, MSH6, PMS2, PTEN, SDHB, SDHC, SDHD, TMEM127, TP53, TSC1, TSC2, VHL
HCE1014
4
LZTR1, NF1, NF2, SMARCB1